Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Solid dosage formulations of an orexin receptor antagonist

Solid dosage formulations of an orexin receptor antagonist

US Patent 11160811 · Granted Nov 2, 2021

Estimated economic value: $152,718,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid dosage formulations of an orexin receptor antagonist2024
Solid dosage formulations of an orexin receptor antagonist2024
Solid dosage formulations of an orexin receptor antagonist2018
Solid dosage formulations of an orexin receptor antagonist2018
Pharmaceutical compositions that inhibit disproportionation2016
Hydrophobic taxane derivatives2001
Preparation of liposomal taxanes2000
Detection of endotoxin levels in liposomes, lipid bilayers and lipid complexes2000
Synthesis of hydrophobic taxane derivatives1999
Hydrophobic taxane derivatives1996